Companies /Healthcare

BioLineRx Ltd

NASDAQ: BLRX Biotechnology
$2.43
▼ $0.05 (−2.02%) today
Markets closed · 11:28pm ET
Today · % change

Fundamentals

Market Cap
$12.0M
Revenue (TTM)
$1.4M
52-Week Range
$2 – $5
Street Target
$22.00

About BioLineRx

BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company is headquartered in Hevel Modi'in, Israel.

BLRX Coverage